Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks after initial injection
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing a new treatment called GAL1906 to see if it can safely and effectively reduce wrinkles in the upper chest area. It focuses on people who want to improve the appearance of their skin in that region.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 weeks after initial injection
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks after initial injection
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
The percentage of responders on the Galderma Décolletage Scale, as assessed live by the Blinded Evaluator, at Week 12.
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: GAL1906Experimental Treatment1 Intervention
Experimental product for correction of wrinkles
Group II: ControlActive Control1 Intervention
No treatment control
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
GAL1906
2021
N/A
~200
Find a Location
Who is running the clinical trial?
Q-Med ABLead Sponsor
80 Previous Clinical Trials
12,485 Total Patients Enrolled
1 Trials studying Wrinkles
110 Patients Enrolled for Wrinkles
Galderma R&DLead Sponsor
302 Previous Clinical Trials
60,445 Total Patients Enrolled
8 Trials studying Wrinkles
1,156 Patients Enrolled for Wrinkles
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Subjects must be willing to comply with the requirements of the study and must provide a written informed consent.You are looking to treat the skin on your upper chest area.You are non-pregnant, non-breastfeeding females, over the age of 21.
Research Study Groups:
This trial has the following groups:- Group 1: GAL1906
- Group 2: Control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Wrinkles Patient Testimony for trial: Trial Name: NCT04717934 — N/A
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger